Hemodynamic effects of com- bination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27:459 66. 2. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consen- sus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Developed in collaboration with the Ameri- can College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573 619. 3. Wang J, Han J, Li Y, et al. Impact of surgical ablation of atrial fibrillation on the progression of tricuspid regurgitation and right-sided heart remodel- ing after mitral-valve surgery: a propensity-score matching analysis. J Am Heart Assoc. 2016;5:e004213. 4. Stulak JM, Schaff HV, Dearani JA, et al. Restoration of sinus rhythm by the Maze procedure halts progression of tricuspid regurgitation after mitral surgery. Ann Thorac Surg. 2008;86:40 4; discussion 44 5. 8.2.3. Timing of Intervention 1. Staab ME, Nishimura RA, Dearani JA. Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: anal- ysis of outcome in 34 patients. J Heart Valve Dis. 1999;8:567 74. 2. Vassileva CM, Shabosky J, Boley T, et al. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg. 2012;143:1043 9. 3. Dreyfus GD, Corbi PJ, Chan KMJ, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79:127 32. 4. Navia JL, Brozzi NA, Klein AL, et al. Moderate tricuspid regurgitation with left-sided degenerative heart valve disease: to repair or not to repair? Ann Thorac Surg. 2012;93:59 67. 5. Benedetto U, Melina G, Angeloni E, et al. 